Evidence map›Paper›PMID 38790136›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Region-Specific CD16

Yan Zhang, Zien Wang, Yu Lu, David J Sanchez, Jiaojiao Li, Linghao Wang, Xiaoxue Meng, Jianjun Chen, Tran Trung Kien, Ming Zhong and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Journal of gastrointestinal oncology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yan ZhangState Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.ORCID 0000-0001-5612-1387
Zien WangState Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Yu LuState Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
David J SanchezPharmaceutical Sciences Department, College of Pharmacy, Western University of Health Sciences, 309 East 2nd Street, HPC 225, Pomona, CA, 90025, USA.
Jiaojiao LiSchool of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Sydney, NSW, 2007, Australia.
Linghao WangMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Xiaoxue MengMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
Jianjun ChenDepartment of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Tran Trung KienOncology department, University Medical Shing Mark Hospital, 1054 Highway 51, Long Binh Tan Ward, Bien Hoa City, Dong Nai, 76000, Vietnam.
Ming ZhongDepartment of Gastrointestinal Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Wei-Qiang GaoState Key Laboratory of Systems Medicine for Cancer, Renji Hospital, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.ORCID 0000-0002-1989-4927
Xianting DingState Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.ORCID 0000-0002-1549-3499

Funding

111 project B21024KC Wong foundationKey Technologies Research and Development ProgramNational Key Research and Development Program of China 2022YFC2601700National Key Research and Development Program of China 2022YFF0710200National Key Research and Development Program of China 2023YFC1404100National Natural Science Foundation of China 22077079National Natural Science Foundation of China 81972670National Natural Science Foundation of China T2122002National Natural Science Foundation of China U23A20441Peak Disciplines (Type VI) of Institutes of Higher Learning in ShanghaiScience and Technology Commission of Shanghai MunicipalityShanghai Jiao Tong University STAR and Scientific and Technological Innovation Funds
6 · The paper itself

Abstract

The colon is the largest compartment of the immune system, with innate immune cells exposed to antigens in the environment. However, the mechanisms by which the innate immune system is instigated are poorly defined in colorectal cancer (CRC). Here, a population of CD16

Indexed as

Colorectal NeoplasmsKiller Cells, NaturalNeutrophilsReceptors, IgGAnimalsDisease Models, AnimalDisease ProgressionGPI-Linked ProteinsHumansMiceGPI-Linked ProteinsReceptors, IgGcholesterolCRCNETneutrophilNK cell

Identifiers

PMID38790136
PMCPMC11304263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.